Results 11 to 20 of about 114,091 (265)

Routine Vaccination Coverage — Worldwide, 2020 [PDF]

MMWR. Morbidity and Mortality Weekly Report, 2021
Endorsed by the World Health Assembly in 2020, the Immunization Agenda 2030 (IA2030) strives to reduce morbidity and mortality from vaccine-preventable diseases across the life course (1). This report, which updates a previous report (2), presents global, regional,* and national vaccination coverage estimates and trends as of 2020.
Muhoza, Pierre, Danovaro-Holliday, M. Carolina, Diallo, Mamadou S., Murphy, Padraic, Sodha, Samir V., Requejo, Jennifer H., Wallace, Aaron S.   +6 more
openaire   +2 more sources

The Moderating Effect of Vaccine Hesitancy on the Relationship between the COVID-19 Vaccine Coverage Index and Vaccine Coverage

Vaccines, 2023
To examine COVID-19 vaccination barriers in the US, this study drew on publicly available county-level data (n = 3130) to investigate the impact of vaccine hesitancy on the relationship between county-level social/structural barriers and vaccine coverage. A hierarchical regression was performed to establish the relationship between the COVID-19 Vaccine
Annalise Julia Tolley, Victoria C. Scott, Mary Louise Mitsdarffer, Jonathan P. Scaccia   +3 more
openaire   +3 more sources

Financial Interventions to Increase Vaccine Coverage [PDF]

Pediatrics, 2020
BACKGROUND: Recent vaccine mandates in Australia, as in other high income settings, have sought to change the behavior of parents, including those who would otherwise access nonmedical exemptions.
Katie, Attwell, Rebecca, Seth, Frank, Beard, Alexandra, Hendry, David, Lawrence   +4 more
openaire   +2 more sources

Vaccination coverage and reasons for non-vaccination in a district of Istanbul [PDF]

BMC Public Health, 2006
Abstract Background In order to control and eliminate the vaccine preventable diseases it is important to know the vaccination coverage and reasons for non-vaccination. The primary objective of this study was to determine the complete vaccination rate; the reasons for non-vaccination and the predictors that influence ...
Bakırcı Nadi, Torun Sebahat D
openaire   +4 more sources

Vaccination coverage, delay and loss to follow-up of the triple viral vaccine, in live births between 2017 and 2018 in Brazilian cities [PDF]

Epidemiologia e Serviços de Saúde
Objective To estimate measles-mumps-rubella vaccination coverage, delay and loss to follow-up in children up to 24 months old living in Brazilian cities.
Tatiana Lang D’Agostini, Fernanda Florencia Fregnan Zambom, José Cássio de Moraes, Ana Paula França, Jéssica Pires de Camargo, Manoel Carlos Sampaio de Almeida Ribeiro, Rita Barradas Barata, Adriana Ilha da Silva, Alberto Novaes Ramos Jr., Ana Paula França, Andrea de Nazaré Marvão Oliveira, Antonio Fernando Boing, Carla Magda Allan Santos Domingues, Consuelo Silva de Oliveira, Ethel Leonor Noia Maciel, Ione Aquemi Guibu, Isabelle Ribeiro Barbosa Mirabal, Jaqueline Caracas Barbosa, Jaqueline Costa Lima, José Cássio de Moraes, Karin Regina Luhm, Karlla Antonieta Amorim Caetano, Luisa Helena de Oliveira Lima, Maria Bernadete de Cerqueira Antunes, Maria da Gloria Teixeira, Maria Denise de Castro Teixeira, Maria Fernanda de Sousa Oliveira Borges, Rejane Christine de Sousa Queiroz, Ricardo Queiroz Gurgel, Rita Barradas Barata, Roberta Nogueira Calandrini de Azevedo, Sandra Maria do Valle Leone de Oliveira, Sheila Araújo Teles, Silvana Granado Nogueira da Gama, Sotero Serrate Mengue, Taynãna César Simões, Valdir Nascimento, Wildo Navegantes de Araújo   +37 more
doaj   +1 more source

Longitudinal profiling of the vaccination coverage in Brazil reveals a recent change in the patterns hallmarked by differential reduction across regions

International Journal of Infectious Diseases, 2020
Objective: Vaccination coverage is decreasing worldwide, favoring the potential reemergence of vaccine-preventable diseases. In this study, we performed a longitudinal characterization of vaccination coverage in Brazil and compared the profiles between ...
Náthaly Césare, Tiago F. Mota, Fernanda F.L. Lopes, Ana Claudia M. Lima, Ricardo Luzardo, Luiz Fernando Quintanilha, Bruno B. Andrade, Artur T.L. Queiroz, Kiyoshi F. Fukutani   +8 more
doaj   +1 more source

Sustained Increase in Very Low Influenza Vaccination Coverage in Residents and Healthcare Workers of Long-Term Care Facilities in Austria after Educational Interventions

Vaccines, 2023
Residents of long-term care facilities (LTCFs) are particularly at risk for influenza infections. We aimed to improve influenza vaccination coverage among residents and healthcare workers (HCWs) in four LTCFs by implementing educational programs and ...
Johannes Boyer, Elisabeth König, Herwig Friedl, Christian Pux, Michael Uhlmann, Walter Schippinger, Robert Krause, Ines Zollner-Schwetz   +7 more
doaj   +1 more source

Age-appropriate vaccination coverage and its determinants for the polio containing vaccine 1-3 and measles-containing vaccine doses in Zhejiang province, China: A community-based cross-sectional study

Human Vaccines & Immunotherapeutics, 2020
Background: This study aimed to evaluate the age-appropriate coverage and its associated risk factors for the primary vaccination of Polio containing vaccine (PCV) and measles-containing vaccine (MCV) through the secondary use of the 2018 Zhejiang ...
Yu Hu, Yaping Chen, Ying Wang, Hu Liang, Huakun Lv   +4 more
doaj   +1 more source

Routine Vaccination Coverage — Worldwide, 2021

MMWR. Morbidity and Mortality Weekly Report, 2022
In 2020, the World Health Assembly endorsed the Immunization Agenda 2030, an ambitious global immunization strategy to reduce morbidity and mortality from vaccine-preventable diseases (1). This report updates a 2020 report (2) with global, regional,* and national vaccination coverage estimates and trends through 2021.
Rachlin, Audrey, Danovaro-Holliday, M. Carolina, Murphy, Padraic, Sodha, Samir V., Wallace, Aaron S.   +4 more
openaire   +2 more sources

Whom and where are we not vaccinating? Coverage after the introduction of a new conjugate vaccine against group A meningococcus in Niger in 2010. [PDF]

PLoS ONE, 2012
MenAfriVac is a new conjugate vaccine against Neisseria meningitidis serogroup A developed for the African "meningitis belt". In Niger, the first two phases of the MenAfriVac introduction campaign were conducted targeting 3,135,942 individuals aged 1 to ...
Sung Hye Kim, Lorenzo Pezzoli, Harouna Yacouba, Tiekoura Coulibaly, Mamoudou H Djingarey, William A Perea, Thomas F Wierzba   +6 more
doaj   +1 more source